Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Recruiting · NCT04183712 · Registry updated 2024-10-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, gallbladder carcinoma, gallbladder disorder, gallbladder neoplasm, neoplasm | Recruiting | Phase 2 | 2024-10-16 | NCT04183712 |
13 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 7 |
| Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | China | 10 |